drugset / Trial / NCT01746420
Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether recombinant human platelet-derived growth factor (rhPDGF-BB) Injection is effective in the treatment of lateral epicondylitis (tennis elbow).
Timeline
- Start
- 2012-12-12
- Primary completion
- 2014-10-21
- Completion
- 2014-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhPDGF-BB | Protein / enzyme biologic | 0.45 mg | Other |
| Subject | rhPDGF-BB | Protein / enzyme biologic | 0.75 mg | Other |
| Subject | rhPDGF-BB | Protein / enzyme biologic | 1.5 mg | Other |
| Subject | rhPDGF-BB | Protein / enzyme biologic | 3 mg | Other |